Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-4-27
|
pubmed:abstractText |
We studied the development of transverse (T)-tubules and sarcoplasmic reticulum (SR) in relationship to myofibrillogenesis in normal and dysgenic (mdg/mdg) mouse skeletal muscle by immunofluorescent labeling of specific membrane and myofibrillar proteins. At E16 the development of the myofibrils and membranes in dysgenic and normal diaphragm was indistinguishable, including well developed myofibrils, a delicate network of T-tubules, and a prominent SR which was not yet cross-striated. In diaphragms of E18 dysgenic mice, both the number and size of muscle fibers and myofibrillar organization were deficient in comparison to normal diaphragms, as previously reported. T-tubule labeling was abnormal, showing only scattered tubules and fragments. However, many muscle fibers displayed cross striation of sarcomeric proteins and SR comparable to normal muscle. In cultured myotubes, cross-striated organization of sarcomeric proteins proceeded essentially in two stages: first around the Z-line and later in the A-band. Sarcomeric organization of the SR coincided with the first stage, while the appearance of T-tubules in the mature transverse orientation occurred infrequently, only after A-band maturation. In culture, myofibrillar and membrane organization was equivalent in normal and dysgenic muscle at the earlier stage of development, but half as many dysgenic myotubes reached the later stage as compared to normal. We conclude that the mdg mutation has little effect on the initial stage of membrane and myofibril development and that the deficiencies often seen at later stages result indirectly from the previously described absence of dihydropyridine receptor function in the mutant.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0012-1606
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
150
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
266-80
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1551475-Animals,
pubmed-meshheading:1551475-Animals, Newborn,
pubmed-meshheading:1551475-Cells, Cultured,
pubmed-meshheading:1551475-Crosses, Genetic,
pubmed-meshheading:1551475-Embryo, Mammalian,
pubmed-meshheading:1551475-Fluorescent Antibody Technique,
pubmed-meshheading:1551475-Gestational Age,
pubmed-meshheading:1551475-Homozygote,
pubmed-meshheading:1551475-Mice,
pubmed-meshheading:1551475-Mice, Mutant Strains,
pubmed-meshheading:1551475-Muscle Proteins,
pubmed-meshheading:1551475-Muscles,
pubmed-meshheading:1551475-Myofibrils,
pubmed-meshheading:1551475-Sarcomeres,
pubmed-meshheading:1551475-Sarcoplasmic Reticulum
|
pubmed:year |
1992
|
pubmed:articleTitle |
Coordinated development of myofibrils, sarcoplasmic reticulum and transverse tubules in normal and dysgenic mouse skeletal muscle, in vivo and in vitro.
|
pubmed:affiliation |
Laboratory of Neurobiology, NINDS, National Institutes of Health, Bethesda, Maryland 20892.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|